← RESMED INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $352.4m | $342.3m | $315.6m | $404.6m | $621.7m | $474.5m | $779.4m | $897.6m | $1.0b | $1.4b | |
| Depreciation, Depletion and Amortization | $86.8m | $112.2m | $120.0m | $150.8m | $154.8m | $156.8m | $159.6m | $165.2m | $176.9m | $198.5m | |
| Depreciation | $86.8m | $112.2m | $120.0m | $150.8m | $65.6m | $78.4m | $81.0m | $84.7m | $88.9m | $111.8m | |
| Amortization of Intangible Assets | $30.2m | $46.6m | $46.4m | $74.9m | $49.6m | $45.1m | $39.6m | $30.4m | $33.0m | $32.1m | |
| Deferred Income Tax Expense (Benefit) | ($996k) | ($4.5m) | $6.9m | ($49.5m) | ($29.9m) | ($16.6m) | ($11.8m) | ($45.4m) | ($49.9m) | ($61.0m) | |
| Share-based Payment Arrangement, Noncash Expense | $46.4m | $45.9m | $48.4m | $52.1m | $57.6m | $63.9m | $65.3m | $71.1m | $80.2m | $91.7m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | $52.4m | $30.6m | $8.8m | $18.1m | |
| Share-based Payment Arrangement, Expense | $46.4m | $45.9m | $48.4m | $52.1m | $57.6m | $63.9m | $65.3m | $71.1m | $80.2m | $91.7m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | — | — | — | $5.0m | $11.7m | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | $14.5m | ($14.5m) | $12.2m | ($9.9m) | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | — | |
| Income (Loss) from Equity Method Investments | — | — | — | ($15.8m) | ($25.1m) | ($11.2m) | ($8.5m) | ($7.3m) | ($1.8m) | $3.6m | |
| Income Tax Expense (Benefit) | $87.2m | $76.5m | $205.7m | $114.3m | $111.4m | $409.2m | $181.0m | $204.1m | $243.8m | $276.8m | |
| Operating Lease, Lease Income | — | — | — | — | $87.9m | $93.4m | $90.1m | — | — | — | |
| Other Nonoperating Income (Expense) | $5.0m | $4.1m | ($8.5m) | ($10.7m) | ($12.2m) | $14.8m | $3.2m | ($5.7m) | ($3.5m) | ($5.3m) | |
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | — | — | — | — | — | $11.2m | $8.5m | $10.1m | ($1.8m) | $3.6m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $27.3m | $63.6m | $32.4m | $18.0m | ($54.4m) | $129.2m | ($19.3m) | $106.5m | $134.3m | $76.7m | |
| Increase (Decrease) in Inventories | ($30.5m) | $41.6m | ($1.5m) | $84.2m | $69.9m | $22.0m | $311.7m | $248.8m | ($172.2m) | $80.2m | |
| Debt and Equity Securities, Unrealized Gain (Loss) | — | — | — | — | — | $11.2m | $8.5m | $10.1m | ($4.0m) | ($10.3m) | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | — | — | $11.2m | ($12.2m) | $9.9m | ($4.0m) | ($10.3m) | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | $11.2m | $4.0m | $3.9m | $1.8m | $389k | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | — | — | — | $11.2m | ($16.2m) | $6.0m | ($4.0m) | ($10.7m) | |
| Foreign Currency Transaction Gain (Loss), before Tax | $4.2m | $5.4m | ($1.5m) | $1.7m | $1.3m | ($753k) | — | — | — | — | |
| Goodwill | $1.1b | $1.1b | $1.1b | $1.9b | $1.9b | $1.9b | $1.9b | $2.8b | $2.8b | $3.0b | |
| Investment Income, Interest | $16.9m | $17.1m | $16.4m | $2.3m | $1.0m | $362k | — | — | — | — | |
| Marketable Securities, Unrealized Gain (Loss) | — | — | — | — | — | — | ($18.3m) | ($1.7m) | ($1.4m) | $1.1m | |
| Nonoperating Income (Expense) | $10.6m | ($7.1m) | ($20.5m) | ($60.4m) | ($76.6m) | ($20.0m) | ($39.8m) | ($30.2m) | ($55.1m) | ($7.8m) | |
| Operating Expenses | $637.5m | $775.9m | $820.3m | $957.3m | $908.1m | $935.4m | $1.0b | $1.2b | $1.3b | $1.4b | |
| Restructuring Costs | — | — | — | — | — | — | $0 | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $547.9m | $414.1m | $505.0m | $459.1m | $802.3m | $736.7m | $351.1m | $693.3m | $1.4b | $1.8b | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $58.5m | $62.2m | $62.6m | $68.7m | $95.3m | $102.7m | $134.8m | $119.7m | $99.5m | $89.9m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $1.0b | $7.3m | $902k | $951.4m | $27.9m | $39.1m | $42.8m | $1.0b | $133.5m | $139.2m | |
| Payments to Acquire Investments | $9.0m | $6.5m | $14.5m | $46.7m | $31.6m | $21.8m | $20.7m | $32.2m | $12.8m | $6.4m | |
| Net Cash Provided by (Used in) Investing Activities | ($1.1b) | ($81.9m) | ($101.8m) | ($1.1b) | ($179.9m) | ($158.5m) | ($229.9m) | ($1.2b) | ($269.8m) | ($200.0m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $1.1b | $450.0m | $350.0m | $1.5b | $1.2b | $90.0m | $288.0m | $1.1b | $105.0m | $0 | |
| Repayments of Long-term Debt | $283.7m | $545.0m | $1.1b | $711.7m | $1.3b | $612.0m | $166.0m | $405.0m | $835.0m | $40.0m | |
| Proceeds from Issuance of Common Stock | $27.7m | $30.2m | $23.3m | $36.7m | $48.2m | $37.8m | $47.4m | $49.1m | $53.1m | $74.4m | |
| Payments for Repurchase of Common Stock | $102.1m | — | $53.8m | $22.8m | — | — | — | — | $150.0m | $300.0m | |
| Dividends paid | $168.1m | $186.3m | $199.5m | $211.7m | $225.1m | $226.7m | $245.3m | $258.3m | $282.3m | $310.9m | |
| Net Cash Provided by (Used in) Financing Activities | $612.6m | ($262.9m) | ($1.0b) | $580.6m | ($317.3m) | ($764.6m) | ($128.4m) | $422.9m | ($1.1b) | ($606.3m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($20.6m) | $21.2m | ($9.7m) | ($5.6m) | $10.9m | $18.5m | ($14.4m) | ($2.1m) | ($1.7m) | $25.8m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($20.6m) | $21.2m | ($9.7m) | ($41.6m) | $316.0m | ($167.9m) | ($21.6m) | ($45.8m) | $10.5m | $971.1m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | $273.7m | $227.9m | $238.4m | $1.2b | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $11.2m | $28.2m | $28.4m | $36.2m | $40.4m | $24.0m | $22.3m | $47.4m | $45.7m | $28.4m | |
| Income Taxes Paid, Net | $69.0m | $92.9m | $170.7m | $242.9m | $180.4m | $221.4m | $478.1m | $216.9m | $278.4m | $214.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.